d) in Electrochemistry Laboratory at Clairo

Hanover, Lower-Saxony, Germany

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Automotive, BatteryIndustries

Requirements

Advanced degree in chemistry, physics, process engineering, electrical engineering or a comparable field of study
Ideally, some initial experience in the chemical-technical or physical-technical field or similar
Confident in using ANSYS Fluent and MS-Office (especially Excel, Word, and PowerPoint)
Strong analytical and research skills, with the ability to interpret data and provide valuable insights
Very good command of English (German is an advantage)
Initiative, commitment, and organizational skills
Knowledge or interest in the Automotive Industry is a plus

Responsibilities

Perform structural and dynamic simulations using LS-DYNA for automotive and battery applications, including vibration and dynamic load scenarios
Conduct electro-thermal modeling in ANSYS Workbench and APDL
Develop and optimize thermal management systems for Li-ion batteries
Utilize Computational Fluid Dynamics (CFD) with ANSYS Fluent for flow and heat transfer analysis in battery manufacturing processes
Apply multi-physics simulation techniques to analyze grid corrosion, thermal behavior, and structural integrity in battery systems

Skills

LS-DYNA

ANSYS Workbench

APDL

ANSYS Fluent

CFD

Excel

Word

PowerPoint

electro-thermal modeling

multi-physics simulation

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free